What is the immunome?
- Authors: Toptygina A.P.1,2
-
Affiliations:
- G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology
- Lomonosov Moscow State University
- Issue: Vol 23, No 1 (2026)
- Pages: 5-11
- Section: Reviews
- URL: https://cijournal.ru/1684-7849/article/view/701112
- DOI: https://doi.org/10.17816/CI701112
- EDN: https://elibrary.ru/PJNRRZ
- ID: 701112
Cite item
Abstract
Advances in Immunology have led to the understanding that the immune system is not only involved in the pathogenesis of various diseases but also plays a key role in maintaining homeostasis and tissue repair. It mediates interactions between the organism and dietary as well as environmental antigens, supports pregnancy, and enables coexistence with the microbiota, highlighting its role as an integrative system of the body.
This review examines the term immunome in both narrow and broad senses, describes key achievements of the Human Immunome Project, and discusses the advantages of this approach for studying the immune system. Initially, the term immunome referred to the repertoire of rearranged antibody genes, as well as T- and B-cell antigen receptors (TCR and BCR). The AIRR-seq technology has been developed for the collection and analysis of adaptive immune receptor repertoires. Knowledge of TCR and BCR repertoires can be applied to the development of modern vaccines against highly dangerous pathogens, rapid vaccine design in response to emerging pathogens, and the creation of personalized vaccines for elderly individuals and specific patient groups. An example of successful application of immunome research in the narrow sense is the development of a Russian drug for the treatment of ankylosing spondylitis. With substantial advances in immunology and biotechnology, the concept of the immunome has expanded. In its broader definition, the immunome includes not only immunocompetent cells, their receptors, and the molecules they produce, but also nonimmune cells and molecules involved in regulating immune responses, as well as the microenvironment in which immune reactions occur. Studies identifying changes in immune cell phenotypes, receptors, transcripts, cytokines, and their associations with disease activity or subtype provide valuable insights. However, their fragmented nature complicates the identification of the pathogenic role of individual factors.
Comprehensive analysis of the immunome facilitates the understanding of immunopathogenesis, the discovery of biomarkers for various diseases, patient stratification, and personalized therapy selection. The extreme complexity of the immunome and its internal interactions necessitates the use of advanced mathematical modeling, bioinformatics, computational tools, and rapidly developing artificial intelligence technologies.
Full Text
About the authors
Anna P. Toptygina
G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology; Lomonosov Moscow State University
Author for correspondence.
Email: toptyginaanna@rambler.ru
ORCID iD: 0000-0002-9981-4762
SPIN-code: 8523-5018
MD, Dr. Sci. (Medicine)
Russian Federation, Moscow; MoscowReferences
- Genomes Project Consortium; Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56–65. doi: 10.1038/nature11632
- Lander ES, Linton LM, Birren B, et al; International human genome sequencing consortium. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860–921. doi: 10.1038/35057062 EDN: LYYXST
- Wasinger VC, Cordwell SJ, Cerpa-Poljak A, et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis. 1995;16(7):1090–1094. doi: 10.1002/elps.11501601185
- NIH HMP Working Group; Peterson J, Garges S, Giovanni M, et al. The NIH human microbiome project. Genome Res. 2009;19(12):2317–2323. doi: 10.1101/gr.096651.109
- The human microbiome project consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. doi: 10.1038/nature11234
- Tweeddale H, Notley-McRobb L, Ferenci T. Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool (“metabolome”) analysis. J Bacteriol. 1998;180(19):5109–5116. doi: 10.1128/JB.180.19.5109-5116.1998
- Toptygina AP. Tissue-resident immune cells in homeostasis and tissue repair. Medical Immunology (Russia). 2025;27(3):475–484. doi: 10.15789/1563-0625-TRI-3156 EDN: CEMPZQ
- Toptygina AP. Role of non-canonical T cells in homeostasis and pathology. Medical Immunology (Russia). 2024;26(3):449–464. doi: 10.15789/1563-0625-RON-2918 EDN: NESGKV
- Pederson T. The immunome. Mol Immunol. 1999;36(15–16):1127–1128. doi: 10.1016/S0161-5890(99)00125-X
- Medzhitov R. The spectrum of inflammatory responses. Science. 2021;374(6571):1070–1075. doi: 10.1126/science.abi5200 EDN: CRGYAE
- De Groot AS, Moise L, McMurry JA, Martin W. Epitope-based immunome-derived vaccines: a strategy for improved design and safety. Clinical Applications of Immunomics. 2008;2:39–69. doi: 10.1007/978-0-387-79208-8_3
- Briney B, Inderbitzin A, Joyce C, Burton DR. Commonality despite exceptional diversity in the baseline human antibody repertoire. Nature. 2019;566(7744):393–397. doi: 10.1038/s41586-019-0879-y
- Soto C, Bombardi RG, Branchizio A, et al. High frequency of shared clonotypes in human B cell receptor repertoires. Nature. 2019;566(7744):398–402. doi: 10.1038/s41586-019-0934-8
- Wooden SL, Koff WC. The human vaccines project: towards a comprehensive understanding of the human immune response to immunization. Hum Vaccin Immunother. 2018;14(9):2214–2216. doi: 10.1080/21645515.2018.1476813 EDN: XAVAPX
- Biancotto A, McCoy JP. Studying the human immunome: the complexity of comprehensive leukocyte immunophenotyping. Curr Top Microbiol Immunol. 2014;377:23–60. doi: 10.1007/82_2013_336
- Yosef N, Regev A. Writ large: genomic dissection of the effect of cellular environment on immune response. Science. 2016;354(6308):64–68. doi: 10.1126/science.aaf5453
- Landhuis E. Single-cell approaches to immune profiling. Nature. 2018;557(7706):595–597. doi: 10.1038/d41586-018-05214-w
- Arnaout RA, Prak ETL, Schwab N, Rubelt F; Adaptive immune receptor repertoire community. The future of blood testing is the immunome. Front Immunol. 2021;12:626793. doi: 10.3389/fimmu.2021.626793 EDN: DAOHGM
- Crowe JE Jr. Influenza virus-specific human antibody repertoire studies. J Immunol. 2019;202(2):368–373. doi: 10.4049/jimmunol.1801459
- Bashford-Rogers RJM, Smith KGC, Thomas DC. Antibody repertoire analysis in polygenic autoimmune diseases. Immunology. 2018;155(1):3–17. doi: 10.1111/imm.12927 EDN: SETCIX
- Tabibian-Keissar H, Hazanov L, Schiby G, et al. Aging affects B-cell antigen receptor repertoire diversity in primary and secondary lymphoid tissues. Eur J Immunol. 2016;46(2):480–492. doi: 10.1002/eji.201545586
- Bian X, Wasserfall C, Wallstrom G, et al. Tracking the antibody immunome in type 1 diabetes using protein arrays. J Proteome Res. 2017;16(1):195–203. doi: 10.1021/acs.jproteome.6b00354
- Conrad C, Gilliet M. Psoriasis: from Pathogenesis to targeted therapies. Clin Rev Allergy Immunol. 2018;54(1):102–113. doi: 10.1007/s12016-018-8668-1 EDN: SUFPZD
- Sennikova SV, Toptygina AP, Kolobov AA, Simbirtsev AS. Treatment-dependent changes in cytokine profile of capillary and venous blood in patients with psoriasis. Medical Immunology (Russia). 2023;25(6):1395–1406. doi: 10.15789/1563-0625-CIT-2592 EDN: JINYRQ
- Gawel DR, Serra-Musach J, Lilja S, et al. A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases. Genome Med. 2019;11(1):47. doi: 10.1186/s13073-019-0657-3 EDN: KFEATN
- Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020;21(6):605–614. doi: 10.1038/s41590-020-0677-6 EDN: ZSWGZE
- Orange DE, Yao V, Sawicka K, et al. RNA identification of PRIME cells predicting rheumatoid arthritis flares. N Engl J Med. 2020;383(3):218–228. doi: 10.1056/NEJMoa2004114 EDN: WLNOYX
- Seyed Tabib NS, Madgwick M, Sudhakar P, et al. Big data in IBD: big progress for clinical practice. Gut. 2020;69(8):1520–1532. doi: 10.1136/gutjnl-2019-320065
- Kosoy R, Kim-Schulze S, Rahman A, et al. Deep analysis of the peripheral immune system in IBD reveals new insight in disease subtyping and response to monotherapy or combination therapy. Cell Mol Gastroenterol Hepatol. 2021;12(2):599–632. doi: 10.1016/j.jcmgh.2021.03.012 EDN: WOPVRI
- Argmann C, Tokuyama M, Ungaro RC, et al. Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension. Gastroenterology. 2021;161(6):1953–1968.e15. doi: 10.1053/j.gastro.2021.08.053 EDN: PPRVWV
- Toptygina AP, Semikina EL, Tsvetkova VS, et al. Dependence of cytokine concentration in coproextracts in children with inflammatory bowel diseases on disease activity. Cytokines and inflammation. 2023;20(2):40–48. doi: 10.17816/CI627073 EDN: EPMIHE
- Falloon KA, Fiocchi C. Current therapy in inflammatory bowel disease: why and how we need to change? EMJ Innov. 2022;6(1):40–49. doi: 10.33590/emjinnov/21-00134 EDN: CIDKNQ
- Alsoud D, Verstockt B, Fiocchi C, Vermeire S. Breaking the therapeutic ceiling in drug development in ulcerative colitis. Lancet Gastroenterol Hepatol. 2021;6(7):589–595. doi: 10.1016/S2468-1253(21)00065-0 EDN: LHWSBG
- Vermeulen R, Schymanski EL, Barabási AL, Miller GW. The exposome and health: where chemistry meets biology. Science. 2020;367(6476):392–396. doi: 10.1126/science.aay3164 EDN: AFGVDX
- Kirchgesner J, Lemaitre M, Carrat F, et al. Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology. 2018;155(2):337–346.e10. doi: 10.1053/j.gastro.2018.04.012
- Fiocchi C, Iliopoulos D. Inflammatory bowel disease therapy: beyond the immunome. Front Immunol. 2022;13:864762. doi: 10.3389/fimmu.2022.864762 EDN: TCPZHA
- Revilla L, Mayorgas A, Corraliza AM, et al. Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis. PLoS One. 2021;16(2):e0246367. doi: 10.1371/journal.pone.0246367 EDN: BPYZCB
- Toptygina A, Grebennikov D, Bocharov G. Prediction of specific antibody- and cell-mediated responses using baseline immune status parameters of individuals received measles-mumps-rubella vaccine. Viruses. 2023;15(2):524. doi: 10.3390/v15020524 EDN: MAMGQB
- Yang X, Garner LI, Zvyagin IV, et al. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature. 2022;612(7941):771–777. doi: 10.1038/s41586-022-05501-7 EDN: PNTVAM
- Britanova OV, Lupyr KR, Staroverov DB, et al. Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis. Nat Med. 2023;29(11):2731–2736. doi: 10.1038/s41591-023-02613-z EDN: HOBFJZ
Supplementary files

